There is a replica version of sotorasib produced by Lucius, which is relatively cheaper than the original research drug,The current selling price is $387.
The price of sotorasib may be influenced by various factors, including production costs, market demand.
Sotorasib, an innovative medication targeting specific genetic mutations in non-small cell lung cancer (NSCLC), has emerged as a novel option for treating this disease owing to its···【more】
Article source:Lucius LaosRelease date:2024-08-05Recommended:143
Sotorasib, a small molecule inhibitor targeting the KRAS G12C gene mutation in non-small cell lung cancer (NSCLC), has garnered significant attention since its debut. Its distincti···【more】
Article source:Lucius LaosRelease date:2024-08-05Recommended:157
Sotorasib emerges as a groundbreaking targeted therapy for non-small cell lung cancer (NSCLC) individuals carrying KRAS G12C alterations. Sotorasib exerts its therapeutic efficacy ···【more】
Article source:Lucius LaosRelease date:2024-07-09Recommended:157
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: